Marlboro

Philip Morris International (PMI), the international tobacco giant responsible for producing Marlboro cigarettes, is approaching the reaching of a £1 billion deal to acquire UK inhaler company Ventura.

Directors at the respiratory health care company have recommended to shareholders that they accept the tobacco maker’s offer.

It comes after a broad group of leading health charities, public health experts and doctors sent a letter to the board calling for them to reject the bid.

The proposed takeover now requires the approval of shareholders holding at least a 50 per cent ownership stake in the company.

Although PMI has repeatedly stated its intention to withdraw from the cigarette market, the vast majority of its revenue comes from selling cigarettes and other ‘combustible’ tobacco products.

As such, health groups have warned that the deal would significantly damage the future prospects of the healthcare company, pushing staff and researchers away.

From a fiscal perspective at least though, it seems the potential deal is working wonders for Ventura, with share values soaring more than a third since May.

Related

Inflation risk re-surging as tensions heat up between Israel and Iran

April 19, 2024
by Robert Fenech

Oil and gold prices jumped after the latest strike by Israel

WATCH: Rare torrential rain in Dubai wreaks havoc and causes major disruption

April 17, 2024
by Anthea Cachia

Flooding hits shopping malls, destroying stock

Spain to end ‘golden visa’ scheme over property market impacts

April 9, 2024
by Anthea Cachia

While countries are slowly banning the practice, Malta remains firm in keeping the scheme alive